Liminatus Pharma (LIMN) Net Income (2024 - 2026)
Liminatus Pharma (LIMN) posted Net Income of -$1.1 million for Q1 2026, down 56.88% sequentially from -$713610.0 in Q4 2025, and down 241.82% YoY from $789429.0 in Q1 2025.
Liminatus Pharma (LIMN) Net Income (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Net Income for 3 years, with the latest figure at -$1.1 million in Q1 2026.
- Quarterly Net Income fell 241.82% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.7 million (down 63.17% YoY) and the FY2025 annual result came in at -$5.2 million, down 47.67% from the prior year.
- Net Income fell to -$1.1 million in Q1 2026 per LIMN's latest filing, from -$713610.0 in the prior quarter.
- Over five years, Net Income peaked at -$327526.0 in Q1 2025 and troughed at -$1.2 million in Q2 2025.
- A 3-year average of -$747850.6 and a median of -$716916.0 in 2025 frame the typical range for Net Income.
- The sharpest annual moves came in 2025 and 2026: Net Income decreased 19.76% in 2025, then plunged 241.82% in 2026.
- Over 3 years, Net Income stood at -$383216.0 in 2024, then slumped by 86.22% to -$713610.0 in 2025, then sank by 56.88% to -$1.1 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$1.1 million, -$713610.0, and -$720222.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Liminatus Pharma | 256.03 Mn | 256.03 Mn | - | -1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.12 Mn |
| Dec 31, 2025 | -713,610.00 |
| Sep 30, 2025 | -720,222.00 |
| Jun 30, 2025 | -1.16 Mn |
| Mar 31, 2025 | -327,526.00 |
| Dec 31, 2024 | -383,216.00 |
| Sep 30, 2024 | -601,372.00 |
| Jun 30, 2024 | -961,207.00 |